European Council agrees on SPC manufacturing waiver

The European Council has reached a political agreement on a proposal for the supplementary protection certificate (SPC) manufacturing waiver for patent-protected pharmaceuticals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

EU adopts SPC manufacturing waiver

16 May 2019 The European Union has adopted the proposed supplementary protection certificate manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Generics

European Parliament approves SPC manufacturing waiver

18 April 2019 The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Big Pharma

SPC waiver stockpiling provision attracts criticism

19 February 2019 While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.

More on this story

Generics

EU adopts SPC manufacturing waiver

16 May 2019 The European Union has adopted the proposed supplementary protection certificate manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Generics

European Parliament approves SPC manufacturing waiver

18 April 2019 The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Big Pharma

SPC waiver stockpiling provision attracts criticism

More on this story

Generics

EU adopts SPC manufacturing waiver

16 May 2019 The European Union has adopted the proposed supplementary protection certificate manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Generics

European Parliament approves SPC manufacturing waiver

18 April 2019 The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Big Pharma

SPC waiver stockpiling provision attracts criticism